Today, we're revealing the nominees for Product Approval. As of November 2011, the US FDA had approved 35 new medicines- many of them important advances for patients. This award will honor the company that has used a novel partnering approach to receive market approval for their product.
The Nominees are:
- - Peter Mueller, CSO and EVP Global R&D, Vertex Pharmaceuticals
- - Jon Lee, Vice President, Development Operations, Cerexa
- - Ann Wang, VP, Clinical Operations & Data Management, Human Genome Sciences, Inc.
Voting will take place next week in Orlando. If you'd like to vote for this category, register to join us for the awards, and mention code XP1700BLOG to receive 15% off the standard rate!